Warning Issued Over Unapproved Retatrutide Weight Loss Drug Sold Illegally Online
By Peak Haven2 min read

Australians are being warned about the dangers of injecting unapproved weight-loss drugs, particularly retatrutide, which are being sold illegally online despite explicit "not for human consumption" disclaimers. These products, often promoted by fitness influencers on social media, pose significant health risks due to their untested nature and potential for contamination.
Key Takeaways
- Unapproved weight-loss drug retatrutide is being sold illegally online, often with "research use only" labels.
- Fitness influencers are promoting the drug on social media, leading to widespread use among the public.
- Experts warn of serious side effects and unknown risks due to the lack of regulation and testing.
- Pharmaceutical companies and regulatory bodies are issuing warnings and taking down illegal advertisements.
The Rise of the "Black Market" Drug
Retatrutide, a synthetic peptide hailed by some as a potential "king of peptides" for weight loss, is currently undergoing phase 3 clinical trials by pharmaceutical giant Eli Lilly. However, it has not yet received approval from any global regulatory body. Despite this, the drug is being widely advertised and sold on various online platforms, often shipped directly to residential addresses. These suppliers frequently label their products as "for research use only" or "not for human consumption," a legal loophole that allows them to skirt regulations.
Social Media Promotion and User Risks
Social media platforms, particularly TikTok, have become a breeding ground for the promotion of retatrutide. Fitness influencers share testimonials, dosage recommendations, and even injecting advice, often downplaying the risks. Users are reportedly purchasing bacteriostatic water and insulin syringes to administer the drug themselves. This trend mirrors the popularity of other GLP-1 agonist drugs like Ozempic, but with the added danger of using an unapproved and potentially counterfeit substance.
Expert Warnings and Potential Side Effects
Experts like Dr. Ian Musgrave, a molecular pharmacologist, emphasize the serious risks associated with these unapproved products. "Retatrutide is still experimental. We don?t know the length and frequency of side effects," he stated. Potential side effects, similar to other GLP-1 drugs, can include severe gastrointestinal issues like complete stomach emptying stoppage, pancreatitis, and bowel obstructions. Furthermore, counterfeit versions may not be properly purified, leading to incorrect folding of the amino acid chains, which can trigger dangerous immune responses, including anaphylaxis.
Regulatory Action and Manufacturer Statements
Eli Lilly, the developer of retatrutide, has stated that no one can legally sell the drug for human use and that counterfeit products are untested, unregulated, and potentially deadly. Regulatory bodies like the Therapeutic Goods Administration (TGA) in Australia and the US Food and Drug Administration (FDA) are aware of the issue and have requested the removal of thousands of illegal advertisements. While TikTok has banned searches for "retatrutide" and removed violating content, the problem persists across various platforms. The lack of stringent customs checks for such substances further complicates enforcement efforts.




